TR201722039A2 - Mesalazi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari - Google Patents

Mesalazi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari Download PDF

Info

Publication number
TR201722039A2
TR201722039A2 TR2017/22039A TR201722039A TR201722039A2 TR 201722039 A2 TR201722039 A2 TR 201722039A2 TR 2017/22039 A TR2017/22039 A TR 2017/22039A TR 201722039 A TR201722039 A TR 201722039A TR 201722039 A2 TR201722039 A2 TR 201722039A2
Authority
TR
Turkey
Prior art keywords
mesalazine
pharmaceutical compositions
solid oral
oral pharmaceutical
derivatives
Prior art date
Application number
TR2017/22039A
Other languages
English (en)
Inventor
Zengi̇ner Si̇bel
Türkyilmaz Ali̇
Taşkin Abdullah
Yanç Burçi̇n
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/22039A priority Critical patent/TR201722039A2/tr
Priority to PCT/TR2018/050894 priority patent/WO2019132837A1/en
Publication of TR201722039A2 publication Critical patent/TR201722039A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, mesalazin veya mesalazinin farmasötik olarak kabul edilebilir bir tuzunu içeren farmasötik kompozisyonlarla ilgili olup; burada söz konusu kompozisyon, akrilik asit ve metakrilik asit ve bunların türevlerini içermemektedir.
TR2017/22039A 2017-12-27 2017-12-27 Mesalazi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari TR201722039A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/22039A TR201722039A2 (tr) 2017-12-27 2017-12-27 Mesalazi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari
PCT/TR2018/050894 WO2019132837A1 (en) 2017-12-27 2018-12-25 Solid oral pharmaceutical compositions of mesalazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/22039A TR201722039A2 (tr) 2017-12-27 2017-12-27 Mesalazi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari

Publications (1)

Publication Number Publication Date
TR201722039A2 true TR201722039A2 (tr) 2019-07-22

Family

ID=65494484

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/22039A TR201722039A2 (tr) 2017-12-27 2017-12-27 Mesalazi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari

Country Status (2)

Country Link
TR (1) TR201722039A2 (tr)
WO (1) WO2019132837A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112315929B (zh) * 2019-07-20 2022-10-28 辽宁华瑞联合制药有限公司 一种四层包衣系统美沙拉嗪肠溶片的组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690824A (en) * 1983-07-07 1987-09-01 Redi-Rowell, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
JPH07223970A (ja) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
AU5775398A (en) * 1996-12-17 1998-07-15 Poli Industria Chimica S.P.A. Site-specific controlled release dosage formulation for mesalamine
US20090169622A1 (en) * 2007-12-27 2009-07-02 Roxane Laboratories, Inc. Delayed-release oral pharmaceutical composition for treatment of colonic disorders
EP3162362A1 (de) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimierte mesalazinhaltige hochdosistablette
CN109310642B (zh) * 2016-04-19 2021-07-20 费灵有限公司 美沙拉嗪的口服药物组合物

Also Published As

Publication number Publication date
WO2019132837A1 (en) 2019-07-04

Similar Documents

Publication Publication Date Title
JOP20200122B1 (ar) مركبات مفيدة لتثبيط cdk7
CY1124726T1 (el) Παραγωγα κιναζολινης που χρησιμοποιουνται για την αντιμετωπιση του hiv
MX2018001990A (es) Composiciones que comprenden un inhibidor de p13k y un inhibidor de hdac.
EA201990388A1 (ru) Пиперидиновые модуляторы рецепторов cxcr7
MX2018010983A (es) Derivado de 3-desoxi y composiciones farmaceuticas del mismo.
UY35933A (es) Composiciones farmacéuticas que comprenden azd9291
MA49947A (fr) Compositions pharmaceutiques contenant des anticorps anti-bêta-amyloïdes
CY1123372T1 (el) Απο toy στοματος φαρμακευτικη συνθεση
EA201891267A1 (ru) Фармацевтическая композиция, содержащая действенный ингибитор urat1
MA40219A (fr) Sels cristallins de (s)-6-((1-acétylpipéridin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
EA202092829A1 (ru) Композиции тофацитиниба с контролируемым высвобождением
EP3694339A4 (en) IMPROVED ANIMAL FEED COMPOSITIONS AND METHODS OF USE
TR201819805T4 (tr) Flavaglin türevleri̇.
MA40366A (fr) Dérivés de tétrahydroquinoline à titre d'inhibiteurs des bromodomaines
EA201890532A1 (ru) Новые аннелированные бензамиды
EA201890534A1 (ru) Новые аннелированные феноксиацетамиды
MX387731B (es) Composiciones farmacéuticas orales de mesalazina.
MX2019003010A (es) Composición farmacéutica de clozapina de liberación prolongada.
MA40781A (fr) Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale
EP4015001A4 (en) Oral pharmaceutical composition
AR090975A1 (es) N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxihexil)amino)-2-oxo-n-fenil-1,2-dihidroquinolina-3-carboxamida
WO2020009675A3 (en) Solid oral pharmaceutical compositions of linagliptin
EP3773613A4 (en) PHARMACEUTICAL COMPOSITIONS WITH POLYROTAXANES
WO2016142821A3 (en) Compositions containing a thrombin inhibitor
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин